AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID19 vaccine using a lower dosage, its chief executive was quoted as saying on Thursday amid questions over the results of its latestage study.from Top India News- News18.com https://ift.tt/36cJUfX
No comments:
Post a Comment